French CAR-T Developer Raises $164M in Follow-on Offering Despite a Challenging Road – Labiotech.eu (blog)
Endpoints News |
French CAR–T Developer Raises $164M in Follow-on Offering Despite a Challenging Road
Labiotech.eu (blog) Cellectis has raised $164M (€132M) in a follow-on offering to further develop its CAR-T technology in clinical trials, despite having mixed results in the technology's development up until now. Cellectis, based in Paris, has closed a follow-on offering … Flush with a $164M raise, Cellectis ups its bet on CAR–T and gene editing programs |
